Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review

BACKGROUND: Phase II clinical trials are a cornerstone of the development in experimental treatments They work as a "filter" for phase III trials confirmation. Surprisingly the attrition ratio in Phase III trials in oncology is significantly higher than in any other medical specialty. This...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Langrand-Escure, Julien, Rivoirard, Romain, Oriol, Mathieu, Tinquaut, Fabien, Rancoule, Chloé, Chauvin, Frank, Magné, Nicolas, Bourmaud, Aurélie
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2017
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5720777/
https://ncbi.nlm.nih.gov/pubmed/29216190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0185536
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg